Ovarian Cancer Project

Join us for a special Lunch & Learn with Natera on Wednesday, May 27th at 12:00 PM (Noon)!

Learn about Signatera™, a molecular residual disease (MRD) test designed to help detect traces of cancer that may remain in the body after treatment. This informative presentation will provide insight into how MRD testing can support ongoing monitoring and care decisions.

📍 Zoom-Only Presentation
📋 Registration Required

To register or learn more, contact Elisabeth Parker at:
📧 [email protected]

We hope you’ll join us for this important educational opportunity.